SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-000245
Filing Date
2020-01-07
Accepted
2020-01-06 18:17:10
Documents
3
Period of Report
2020-01-06
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K atos20200106_8k.htm 8-K 31255
2 EXHIBIT 3.1 ex_168672.htm EX-3.1 8219
3 EXHIBIT 3.2 ex_168682.htm EX-3.2 103958
  Complete submission text file 0001437749-20-000245.txt   144639
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA THERAPEUTICS, INC. (Filer) CIK: 0001488039 (see all company filings)

IRS No.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35610 | Film No.: 20511459
SIC: 2834 Pharmaceutical Preparations